Full-scale test of ammonia two-stroke engine: What it means for the future
The development of ammonia-powered engines has taken a significant step forward with the commencement of full-scale testing of…
Global Pharma News
The Role of Aminoscience in Regenerative Medicine
Regenerative medicine is indeed a transformative frontier in healthcare, with its potential to address previously untreatable conditions and…
Gland Pharma’s Latanoprost Solution: FDA Approved
Gland Pharma has received approval from the United States Food and Drug Administration (USFDA) for its Latanoprost Ophthalmic…
Promising Approaches in HIV Cure Research: Targeting Latent Reservoirs
Targeting molecules involved in the establishment maintenance, and reactivation of the latent HIV reservoir is indeed a promising…
Dr. Reddy’s launches Toripalimab in India, the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma
Proud to announce the launch of Toripalimab in India, the first and only immuno-oncology drug approved by various…
Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide
Potential first and only DHE autoinjector for tough-to-treat migraines and cluster headaches Exenatide approval highlights Amneal’s capabilities in…
Cefepime – Enmetazobactam Antibiotic Launch | Orchid Pharma & Cipla Partnership
Orchid Pharma Limited, (‘Orchid Pharma’) based in Chennai, India, the only Indian pharmaceutical company to have ever invented…
Indoco Remedies receives final ANDA approval from USFDA for Varenicline Tablets, 0.5 mg and 1 mg
Indoco Remedies Ltd. announced the final approval of the Company’s Abbreviated NewDrug Application (ANDA) for Varenicline Tablets, 0.5…
“Animal Health Merger: SeQuent Scientific and Viyash Lifesciences Create Global Leader | Animal Health Insights”
SeQuent Scientific and Viyash Lifesciences Announce Strategic Merger to Create a Global AnimalHealth Leader with End-to-End Integrated Capabilities…
Dr. Reddy’s Laboratories received Voluntary Licence from Gilead to make the latest generation HIV drug
Dr. Reddy’s Laboratories received Voluntary Licence from Gilead to make the latest generation HIV drug, lenacapavir, accessible to…